Homeostasis of chromosomal instability (CIN) facilitates the origin and evolution of abnormal karyotypes that are critical for the survival and proliferation of cancer cells, but excessive CIN can result in cellular toxicity. Geraniin is a multifunctional ellagitannin found in some species of Geranium and Phyllanthus. We employed the cytokinesis-block micronucleus cytome assay to evaluate the CIN, nuclear division index (NDI) and apoptosis induced by geraniin in human colorectal adenocarcinoma cells (Colo205 and Colo320) and human colon mucosal epithelial cells (NCM460). Cells were exposed to 25, 50 or 100 μg/ml geraniin for 24, 48 or 72 h. 0.05 μg/ml mitomycin C was used as a positive control and media as a negative control. The results showed that, compared to negative controls, geraniin significantly reduced NDI (P < 0.01) and increased CIN (P < 0.01) and apoptosis (P < 0.05) in Colo205 and Colo320 cells in a dose-and time-dependent manner. Conversely, geraniin significantly increased NDI (P < 0.05) and decreased CIN (P < 0.001) and apoptosis (P < 0.01) in NCM460 cells. Moreover, CIN was positively associated with apoptosis (r = 0.437, P < 0.001) and negatively associated with NDI (r = -0.744, P < 0.001) in these cells. Together, our results highlight that the induction of catastrophic CIN may underlie the antitumor potential of geraniin. Our data also suggest that geraniin can decrease the risk of oncogenic transformation via decreasing CIN in normal cells.
Introduction
Chromosome is the largest unit of organisation of the eukaryotic genome. Its stability ensures the preservation of genome integrity and promotes faithful genome propagation. Although numerous processes are tightly coordinated to ensure chromosomal stability in normal cells, cells are constantly under attack by chromosome damaging agents of both exogenous and endogenous origin and these assaults can lead to changes in the number and structure of chromosomes-referred to as chromosomal instability (CIN). It has been firmly established that CIN contributes to a variety of complex developmental disorders such as cancer (1) .
Cancer is one of the major public health problems worldwide and the leading cause of death in economically developed countries (2) . CIN and cancer are intertwined in a complex web: CIN is a hallmark of most solid tumours and is highly associated with cancer stage transition. It has been suggested that CIN may contribute to the initiation and progression of cancer by facilitating the appearance of cancer-causing karyotypes (3) . These abnormal karyotypes will activate and/or enhance multiple pathways that are integral to the survival and proliferation of the cancer cells, such as inflammation, immune system evasion or apoptosis resistance (3) . However, this intrinsic feature that distinguishes cancer cells from their normal counterparts carries the promise to selectively target them, because it confers a state of increased basal CIN stress, making cancer cells vulnerable to further augment CIN generation (4) (5) (6) . However, the traditional genotoxic agents used for cancer chemotherapy not only induce CIN to tumour cells but also to normal cells. The induced CIN in normal cells can promote pro-oncogenic mutations in cancerchemotherapy survivors, leading to an increased risk of secondary cancers (7) . Therefore, identification of novel agents that target cancer cells by selectively elevating CIN beyond the therapeutic threshold, while leaving normal cells unaffected provides a new window of opportunity to improve the outcomes of cancer treatment (1) .
Polyphenols constitute one of the most numerous and ubiquitous groups of plant metabolites and provide a rich source for new drug development, particularly drugs in the area of cancer (8) . Tannins are one subgroup of polyphenols that can be further divided into three major groups: hydrolysable tannins, non-hydrolysable/condensed tannins and phlorotannins. Ellagitannins, which belong to the hydrolysable tannin group, are polyesters of a sugar moiety and various numbers of hexahydroxydiphenoyl. Geraniin ( Figure 1A ) is a typical ellagitannin because it is made up of a glucopyranose esterified to three common acyl moieties, namely a galloyl, a hexahydroxydiphenoyl and a dehydrohexahydrodiphenoyl group (9) . The natural occurrence of geraniin has been verified in ethnopharmacological important plants, such as a broad species of genus Geranium (e.g. Geranium sibiricum and G. thunbergii) and Phyllanthus (e.g. Phyllanthus emblica and P. amarus), highlighting its role as an active ingredient in traditional medicines (10) . A large number of in vitro and in vivo animal experiments have reported that geraniin exhibits highly antioxidative, antihypertensive, antihyperglycemic, antiviral and antibacterial, antimutagenic and radioprotective, hepatoprotective, anti-inflammatory, immunomodulatory and antitumor activities (9, 10) . Although various biological and pharmacological effects of geraniin have been revealed, the possible role of geraniin on modulation of CIN in human cancer cells and their normal counterparts has not been elucidated.
In the present study, we intend to determine whether geraniin has potential to selectively elevate CIN in cancer cells. Two human colorectal cancer (CRC) cell lines (Colo205 and Colo320) and a noncancerous colon cell line (NCM460) were treated by geraniin and their CIN levels were measured via the cytokinesis-block micronucleus cytome (CBMN-Cyt) assay. In CBMN-Cyt assay, the endpoints of micronucleus (MN), nucleoplasmic bridge (NPB) and nuclear bud (NB) provide a reliable measure of numerical CIN and structural CIN at a post-mitotic interphase (11) . Moreover, the proliferation (B-D) Colo320, Colo205 and NCM460 cells with a seeding density of 1 × 10 5 /ml were incubated without or with geraniin (1.6-100 μg/ml) for 24 (B), 48 (C) and 72 h (D), then cells were harvested and the total cell numbers were determined by counting live cells on a hemacytometer with the inclusion of trypan blue. Comparison was made by using one-way ANOVA (P = 0.004) with Tukey's post hoc test. Values are presented as mean ± S.E.M. (n = 3). *P < 0.05, **P < 0.01 and ***P < 0.001 compared with corresponding control.
(nuclear division index, NDI) and cell death (apoptosis and necrosis) were also determined by CBMN-Cyt assay.
Materials and methods

Chemicals
Geraniin (purity: 99%) was obtained from Amresco (Cleveland, OH). A stock solution of geraniin was prepared by dissolving the powder in RPMI 1640 medium at 1 mg/ml. The solution was filtered through a 0.22-μm pore size hydrophilic polyethersulfone membrane (Merck Millipore, MA) and stored at -80°C. The stock solution was thawed at 4 °C and diluted to the desired concentration in medium immediately before use. 
Cell lines and cell culture
Cell viability tests
Cell viability was tested by trypan blue exclusion. NCM460, Colo320 and Colo205 were seeded into 24-well plates (Corning, NY, USA) at a density of 1 × 10 5 cells/ml and exposed to different geraniin doses (0, 1.6, 3.1, 6.2, 12.5, 25, 50, 100 μg/ml) in triplicates. After every 24 h of incubation, one replicate was used for cell viability testing. NCM460, Colo320 and Colo205 cells were detached from plates with 0.25% trypsin (Gibco, NY) and cells were suspended with medium after trypsin discarded. Cell suspension (5 μl) were stained with 5 μl trypan blue (Boster, Wuhan, China) and counted in a hemocytometer. This procedure was repeated three times.
Cytokinesis-block micronucleus cytome (CBMN-Cyt) assay CBMN-Cyt assay is a well-established system that allows CIN, cytotoxic and cytostatic events to be captured within one assay (11) . CBMN-Cyt assay was performed as described previously (12, 13) . Briefly, NCM460, Colo320 and Colo205 cells were seeded into 24-well plates at a density of 1 × 10 5 cells/ml and allowed to attach overnight. After this period, cells were cultured in RPMI1640 medium containing 0, 25, 50, 100 μg/ml geraniin for 24, 48 or 72 h, respectively. Mitomycin C (MMC; Sigma, MO), a direct-acting clastogen and a commonly used chemotherapeutic agent (14) , was used as the positive control at a final concentration of 0.05 μg/ml. The medium was discarded after treatment, and cells were washed twice with Hanks' balanced salt solution (HBSS). Geraniin-free fresh medium with cytochalasin-B (Cyto-B; 4.5 μg/ml; Sigma, MO) was added to each culture to block cytokinesis. Cyto-B was rinsed with HBSS after a further 24 h, cells were detached from plates with 0.25% trypsin and resuspended in 200 μl fresh medium. Cells were centrifuged onto glass slides using a cyto-centrifuge for 5 min at 800 rpm (100 × g). The final cell density per slide was kept between 0.5 × 10 5 and 1 × 10 5 cells. After drying briefly in air, slides were fixed in fresh 3:1 methanol and glacial acetic acid for 10 min and stained with 10% Giemsa (San'ersi Reagent CO., LTD, Shanghai, China), which could stain cytoplasm and nucleus differentially. The slides were washed twice in ddH 2 O, then allowed to air dry and cover slip. Stained slides were encoded to ensure a blind microscopic analysis, and such a code was removed until the whole microscopic analysis was finished. All biomarkers of CBMN-Cyt assay were scored under 1000 × magnification with optical microscope (Olympus, Tokyo, Japan) using previously described criteria (15) . 
Statistical analysis
The Kolmogorov-Smirnov (KS) test was used to test the normality of all data sets. The differences of observed values among the control and geraniin-treated groups were analyzed using One-way analysis of variance (ANOVA). First, Levene's test was performed to examine the homogeneity of variances among the control and geraniin-treated groups. Post-hoc tests [A Tukey's test was used when the equality of variances assumption holds (P > 0.05), and the Dunnett T3 test was used otherwise (P < 0.05)] once a significant effect was detected. The correlation between the biomarkers investigated was evaluated by Pearson correlation analysis. Data in all figures and tables represent the means ± the standard error of the mean (S.E.M.) of three independent experiments. Only differences having a P-value (two-tailed) lower than 0.05 were considered as being significant. All statistical analyses were performed using SPSS 17.0 for windows (SPSS, Chicago, IL) and graphed by GraphPad PRISM 5.0 (GraphPad, San Diego, CA).
Results
The choice of appropriate concentrations of geraniin
To obtain the appropriate concentrations of geraniin for this study, we obtained the concentration-response curves of geraniin to NCM460, Colo320 and Colo205 cells. As shown in Figure 1B -D, treatment of Colo205 cells with geraniin resulted in a dose-and timedependent reduction of cell number (P < 0.05). Geraniin showed a moderate toxicity with a median inhibitory concentration (IC 50 ) 48.20, 41.50 and 34.78 μg/ml after 24, 48 and 72 h treatment, respectively. Geraniin at 1.6-12.5 μg/ml had no obvious cytotoxicity to Colo320 cells, beyond which (25-100 μg/ml), geraniin exhibited a dose-and time-dependent cytotoxicity to Colo320 cells (P < 0.05; Figure 1B -D). Compared to Colo205, Colo320 cells were found to be slightly less susceptible to geraniin, with an IC 50 50.33 μg/ml after 72 h treatment.
On the other hand, the response of NCM460 to geraniin followed a bell shaped dose-response curve at all time intervals. As shown in Figure 1B -D, NCM460 cells treated with low concentrations of geraniin (1.6-12.5 μg/ml) had higher viability compared with that from untreated control or that treated with high geraniin concentrations (25-100 μg/ml) (P < 0.05). Within the dose and time range evaluated, geraniin had essentially no inhibitory impact on the viability of NCM460 cells, indicating that geraniin could selectively kill CRC.
Based on these results, we chose geraniin at concentrations of 25, 50 and 100 μg/ml (26.25, 52.5 and 105 μM, respectively) for the following experiments. Under this concentration range, geraniin had a high cytotoxicity to CRC while no cytotoxicity to noncancerous colon cells, thus providing a suitable condition to test our hypothesis.
Oppsite roles of getaniin in regulating CIN between CRC and noncancerous cells
The effects of geraniin on CIN of NCM460, Colo320 and Colo205 were investigated by the well-estimated CBMN-Cyt assay (11) . Photomicrographs of the different endpoints scored in CBMN-Cyt assay are shown in Figure 2A -D. The results showed that geraniin significantly increased the frequency of MN and NPB in Colo320 cells in a dose-and time-dependent manner (P < 0.01; Table 1 ). The potential of geraniin in increasing MN frequency maximised after 72 h treatment, with a 4.42-fold increase at the highest scorable dose (50 μg/ml; P < 0.001); while the potential in increasing NPB frequency maximised after 48 h treatment, with a 7.11-fold increase at 100 μg/ml (P < 0.001). However, geraniin was found to have no obvious impact on the NB frequency ( Table 1) .
As shown in Table 2 , a similar dose-and time-dependent increase of MN and NPB by geraniin was also observed in Colo205 cells. The potential of geraniin in increasing MN and NPB frequencies maximised after 48 h treatment, with a 4.58-and 5.73-fold increase at 100 μg/ml, respectively (P < 0.001). Moreover, geraniin showed potential to significantly increase NB frequency in Colo205 cells, with a 4.10-, 4.10-and 4.08-fold increase at 100 μg/ml after 24, 48 and 72 h treatment, respectively (P < 0.05, P < 0.001 and P < 0.01, respectively).
When compared with the control group, a dose-and timedependent decrease in MN, NPB and NB frequencies was observed in NCM460 cells after geraniin treatment (Table 3 ). The potential of geraniin in decreasing MN, NPB and NB maximised after 24 h treatment, with a 76.59, 53.71 and 70.22% decrease at 100 μg/ml, respectively (P < 0.001). Taken together, these data demonstrated that geraniin could specifically increase CIN in CRC cells while decreasing it in noncancerous colon cells.
Selective cytostatic effect of geraniin on CRC
The NDI in CBMN-Cyt assay provides a measurement of the proliferative status after geraniin treatment (11) . The results in Figure 3A and 3B showed that geraniin treatment could decrease the NDI (increase % cytostasis) in Colo320 and Colo205 cells in a dose-and time-dependent manner (P < 0.01), when compared to corresponding untreated controls. Geraniin exhibited the most predominant potential (P < 0.001) in increasing cytostasis in Colo205 and Colo320 after 48 and 72 h, respectively. At these intervals, geraniin at 100 μg/ml caused a nearly 90% of cytostasis in both CRC cell lines.
The NDI of NCM460 was found to be significantly increased after geraniin treatment, in a way depended on the treated dose and time (P < 0.01; Figure 3C ). After 72 h treatment, geraniin showed the most predominant capacity to promote NCM460 proliferation, with a 72.96% promotion at 100 μg/ml (P < 0.001). Taken together, these data demonstrated that geraniin could selectively induce cytostasis in CRC cells while promoting proliferation in noncancerous colon cells.
Selective pro-apoptotic effect of geraniin on CRC
The effects of geraniin on cell death (apoptosis and necrosis) of Colo320, Colo205 and NCM460 were investigated by CBMN-Cyt (MN, B) , a nucleoplasmic bridge (NPB, C) or a nuclear bud (NB, D) are shown (indicated by arrows). A mononucleated cell (E) and a BNC (F) at early stage of apoptosis with chromatin condensation and intact cytoplasmic and nuclear boundaries as well as cells exhibiting nuclear fragmentation into smaller bodies within an intact cytoplasmic membrane. A mononucleated cell (G) and a BNC (H) at late stage of necrosis with cytoplasm loss, swelled nuclear and damaged nuclear membrane with only a partially intact nuclear structure and often with nuclear material leaking from the nuclear boundary. Giemsa-stained DNA is in red, and the cytoplasm is in blue. Bar, 10 μm. assay ( Figure 2E-H) . The results showed that geraniin could significantly induce apoptotic cell death in CRC cells. As shown in Figure 4A -C, the percentages of morphologically apoptotic cells in Colo320 and Colo205 were significantly increased as geraniin concentration elevated (P < 0.05). The apoptotic response to geraniin was stronger in Colo320 than that in Colo205. After 72 h treatment, geraniin at 100 μg/ml induced an over 11-fold increase of apoptosis in Colo320 (P < 0.001), whereas only a 3.44-fold increase in Colo205 (P < 0.001). In contrast, apoptosis frequency in NCM460 cells was found to be significantly decreased after geraiin treatment, in a dose-and time-dependent manner (P < 0.01). When compared to the corresponding controls, geraniin at 100 μg/ml caused a 27.76, 48.53 and 63.83% decrease in apoptosis of NCM460 cells after 24, 48 and 72 h treatment, respectively (P < 0.001). In contrast to apoptosis, geraniin was found to significantly decrease the necrosis frequency in Colo320 after 24 h treatment (P < 0.001; Figure 4D ) and in Colo205 cells after 48 h treatment (P < 0.001; Figure 4E ), as well as in NCM460 cells after 24 h treatment (P < 0.001; Figure 4F ).
Associations of apoptosis and NDI with CIN
To determine whether the alteration of CIN induced by geraniin was associated with the changes in apoptosis and cytostasis, we analyzed the relationships between CIN and apoptosis, CIN and NDI using data from Colo320, Colo205 and NCM460 cells. Of note, we used the relative changes of these biomarkers for the correlation analysis due to the different baselines of CIN, apoptosis and NDI among these cell lines. As expected, there was a statistically significant (P < 0.001) positive association (Pearson correlation coefficient = 0.437) between CIN and apoptosis ( Figure 5A ). In addition, a statistically significant (P < 0.001) negative association (Pearson correlation coefficient = -0.744) was found between CIN and NDI ( Figure 5B ). Together, these results suggested that the induction of apoptosis and cytostasis in CRC cells by geraniin might be attributed to the increased CIN in them.
Discussion
In this study, we show, for the first time, that geraniin has potential to selectively promote catastrophic CIN in CRC cells followed by cytostasis and apoptosis. Intriguingly, although geraniin is highly genotoxic to CRC cells, it reduces CIN in noncancerous colon cells at the same concentrations.
One predominant hallmark that distinguishes cancer cells from their noncancerous counterparts is CIN. The acquisition of CIN Data represented the mean frequency ± the standard error of the mean (S.E.M.) per 1000 BNCs from three independent experiments. Significant differences between geraniin-treated groups and controls at each treatment interval are indicated by *P < 0.05, ** P < 0.01 and *** P < 0.001. MMC (mitomycin C) was used as a positive control. NA, not analyzed. Data represented the mean frequency ± the standard error of the mean (S.E.M.) per 1000 BNCs from three independent experiments. Significant differences between geraniin-treated groups and controls at each treatment interval are indicated by *P < 0.05, ** P < 0.01 and *** is an important mechanism for tumour evolution and associates with a poor prognosis(1). However, it has been suggested that there is an optimal level of CIN in tumours required for tumour adaptation and progression, beyond which CIN becomes unfavourable because it destroys the genome and, therefore compromises clonal expansion (17) . To date, only limited studies provided evidence that specific cellular stress resulting from massive CIN induced by genetic methods can indeed be utilised as a strategy to kill tumour cells (4) (5) (6) , as well as a relationship between high levels of CIN and survival outcome in cancers (18) . In fact, we have previously noted that P. emblica uses this strategy to selectively kill Colo320 cells (16) . In this study, we confirmed this notion by highlighting that geraniin kills CRC cells through inducing catastrophic CIN in them, indicating a new mechanism underlying the anticancer action of geraniin.
The exact mechanisms underlying geraniin-induced catastrophic CIN in Colo320 and Colo205 cells remain to be determined. One potential explanation is that geraniin inhibited Heat shock protein 90 (HSP90) in these cells (19) . HSP90 is a molecular chaperone participates in maturating, stabilizing and activating numerous client proteins involved in cell signaling and survival (20) . In particular, HSP90 involves in the spindle assembly checkpoint (SAC) that governs the fidelity of chromosome transmission (21) . Moreover, HSP90 interacts with several other pathways that could affect chromosome transmission fidelity, including the kinetochore assembly (22) . Geraniin is able to inhibit the in vitro HSP90 ATPase activity in a dose-dependent manner, with an inhibitory efficiency higher than that measured for 17-AAG, a well-known HSP90 inhibitor currently undergoing phase II/III clinical trials. In yeast, HSP90 inhibition by radicicol and Macbecin II is the most potent inducer of CIN among the various types of stresses tested, including oxidative stress, osmotic stress, endoplasmic reticulum stress, replicative stress, translational stress, membrane integrity defect and spindle assembly defect (21) . Previously, 17-AAG was found to induce CIN in HeLa and HCT116 cells in vitro (23) and in a mouse sarcomatosis model (24) .
In addition to SAC, checkpoint that govern sister chromatids segregation is decatenation checkpoint. DNA topoisomerase II (TOP2) plays an important role in activation of this checkpoint (25) . Geraniin has found to been a potent inhibitor of TOP2, which completely inhibit TOP2 activity at a concentration of 500 nM in vitro (26) . When TOP2 function is blocked, cells fail to separate sister chromatids due to a failure to resolve sister chromatid cohesion (27) . In addition, simultaneously perturbing HSP90 and TOP2 can synergistically induce catastrophic CIN in CRC cells (28) . In light of these findings, we predict that geraniin-induced CIN in Colo320 and Colo205 cells may be a combined effect of interfering the function of HSP90 and TOP2. If so, we speculate that geraniin-induced MN usually derived from whole chromosomes. Further study aims to determine whether the geraniin-induced MN harbor whole chromosomes or chromatin fragments will provide insights into our speculation.
Our data highlighted that CIN was positively associated with cytostasis and apoptosis. These data looks like paradoxical considering that division is needed to 'express' CIN biomarkers in CBMN Cyt assay. A potential explanation for our results is that HSP90 inhibition induces downregulation of critical HSP90 protein clients and results in mitotic arrest (29) . Upon prolonged mitotic arrest, cancer cells exhibit multiple fates: Some cells slipped through mitosis without any signs of division, while others clearly died in mitosis. Some of those that slipped through mitosis died in interphase (30) . In addition, a small proportion of cells divided and incorrectly separated their chromosomes, resulting CIN in daughter cells that display a high frequency to die in interphase (30) . In light of this view, we speculated that CRC carrying catastrophic CIN induced by geraniin will lose their proliferation capacity and/or be cleared by apoptosis. In line with this, 17-AAG has been shown to induce cytostasis and apoptosis in human CRC (29) . Although this finding was only obtained from CRC, we expect that the observed phenomena is generally applicable to different cancer cells. CIN is frequently seen in many human tumours and these cells express more HSP90 and TOP2 to overcome stresses generated from CIN (27, 31) . Therefore, induction of catastrophic CIN, possible through inhibition of HSP90 and TOP2, may be a mechanism underlying geraniin-induced apoptosis seen in human glioma (32) , breast cancer (33), ovarian cancer (34), lung cancer cells (35) and melanoma cells (36) .
As mentioned, since many client proteins of HSP90 are involved in cell cycle regulation, some Hsp90 inhibitors may perturb physiological functions in normal cells. Recently, HSP90 inhibitor CH5164840 is found to induce MN in human TK-6 lymphocytes via an aneugenic mechanism (37) . In this study, however, we do not find any genotoxic effect of geraniin to NCM460 cells. The selective induction of CIN in CRC distinguishes geraniin from other HSP90 inhibitors, and could be partially explained by geraniin may possess a much higher binding affinity for HSP90 from cancer cells than does HSP90 from normal cells, as occurs in 17-AAG (38) . Moreover, an interesting find is that geraniin-reduced CIN in NCM460, although the underlying mechanisms remain to be further Data represented the mean frequency ± the standard error of the mean (S.E.M.) per 1000 BNCs from three independent experiments. Significant differences between geraniin-treated groups and controls at each treatment interval are indicated by *P < 0.05, ** P < 0.01 and *** explored. We previously showed that P. emblica, a functional food and folk medicine contains geraniin, decrease the CIN via activating the SAC of NCM460 cells (39) . Therefore, we speculate that geraniin might activate the SAC in NCM460 cells. It will be interesting to explore whether geraniin has the potential to recapitulate the phenomenon observed in P. emblica. Anyhow, this finding suggests geraniin is also a promising candidate for cancer chemoprevention since pharmacological reinforcement of surveillance mechanisms against CIN in noncancerous cells offers a promising strategy for reducing oncogenic transformation (40) . In this context, increased proliferation and decreased apoptosis, two hallmarkers of cancer, seen in geraniin-treated NCM460 cells do not mean geraniin has potential to induce oncogenic transformation of noncancerou colon cells, but indicate that it will help to maintain colonic epithelial barrier function, thereby preventing the mucosal invasion of intraluminal microorganisms.
A striking unexpected finding was that geraniin suppressed necrosis in CRC cells. Necrosis is a type of programmed cell death that has a prominent role in multiple physiological and pathological settings (41) . Remarkably, necrosis involves in cell survive when tumour become oxygen-and nutrient-deprived. For example, necrosis is accompanied by mitochondrial dysfunction with enhanced generation of reactive oxygen species (42) , which exerts a key role in several hallmarks of cancer such as self-sufficiency in proliferation signals (43) . Moreover, the necrotic centre of a tumour releases angiogenesis-promoting factors that diffuse out of the tumour, reach the sprout tips, guide their chemotaxis and branching behaviour, and ultimately determine the vascular topology (44) . These insights strongly support the notion that, by impairing the proliferation and metastasis of cancer cells, the inhibition of necrotic cell death may be a more promising target for effective antitumour therapy, although the inducers of necrosis might be theoretically useful for the treatment of apoptosis-resistant tumours (45) .
The in vivo effects of geraniin are largely dependent on its pharmacokinetics and bioavailability. Existing evidence on the absorption and metabolism of geraniin upon oral ingestion is fairly limited. Generally, intact geraniin is rarely found in the circulation after oral dosing because of its large molar mass, which does not facilitate simple diffusion very effectively (9) . Rather, geraniin is hydrolysed by the intestinal bacteria to various metabolites (gallic acid, pyrogallol, ellagic acid and urolithins) which are subsequently absorbed by the small intestine and the colon and persists in the body for a relatively long duration (46) . These metabolites exhibit Figure 4 . Influence of geraniin treatment on the apoptosis and necrosis frequencies of Colo320, Colo205 and NCM460 cells. Colo205, Colo320 and NCM460 cells were incubated with the indicated concentrations of geraniin for 24, 48 or 72 h followed by 24 h of recovery time for cell death assay. Then cells were fixed and the apoptosis frequency (A-C) and necrosis frequency (D-F) were determined. All measurements were set relative to the values measured in corresponding untreated control cells, which were arbitrarily set at 1. Values are presented as mean ± S.E.M. (n = 3). *P < 0.05, **P < 0.01 and ***P < 0.001 compared with the corresponding control.
more potent antioxidant activity compared to geraniin, and may be the key players (particularly urolithins) that account for the bioactivities and final health benefits of geraniin (47) .
Our present findings have two major potential implications. First, we previously found the extract of P. emblica fruit can elevate CIN in Colo320 cells (16) while decrease CIN in NCM460 cells (15, 16) . The faithful recapitulation of these observations by geraniin, therefore, provides compelling evidence that geraniin is one major bioactive component of P. emblica. Further studies, therefore, can be conducted to test whether geraniin is also responsible for many other beneficial effects of this functional food and folk medicine on human health. Second, our present results will provide some clues to investigate the anticancer mechanisms of other natural occurring HSP90 and/or TOP2 inhibitors, such as epigallocatechin gallate, curcumin and resveratrol. NDI; B) . Pearson correlation analysis performed using data from NCM460, Colo320 and Colo205 cells. Due to the different baselines of CIN, apoptosis and NDI among these cell lines, relative changes of CIN, apoptosis and NDI were used for analysis. The solid line is the weighted regression. r, Pearson's correlation; n, the total quantified pairs. Figure 6 . Model summarizing our data. Homeostasis of chromosomal instability (CIN) can facilitate the evolution of advantageous karyotypes that are integral to the survival and proliferation of cancer cells. Geraniin treatment disrupts this homeostasis by elevating the frequency of catastrophic CIN, which results in cellular toxicity and apoptosis in cancer cells. CIN, on the other hand, can also contribute to the tumorigenicity of normal cells. Geraniin reduces CIN in normal cells, and therefore reduces their risk of oncogenic transformation. Although the underlying molecular mechanisms remain to be fully understood, we hypothesise that the inhibition of HSP90 and TOP2 and the activation of spindle assembly checkpoint (SAC) may account for the opposite roles of geraniin in regulating CIN between cancer and normal cells.
There are, however, two limitations in this study. First, there is only limited number of CIN endpoints were investigated. Some other CIN events that cannot be detected by CBMN-Cyt assay, such as multinucleation/polyploidy, centrosome aberrations (amplification, fragmentation and declustering) and mitotic multipolarity, need to be further characterised. Second, we focused this study on detailed analysis of the impacts of geraniin on CIN using in vitro cell models. Whether these effects are applicable to in vivo models need to be determined.
In summary, geraniin shows potential to selectively kill CRC by further augmenting CIN stress, while it is nontoxic to noncancerous colon cells but may also act on pathways that prevent against CIN ( Figure 6 ). Hence, our findings not only uncover a basis for the anticancer effect of geraniin, but also suggest the potential application of geraniin for cancer chemoprevention.
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